Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

TMO Thermo Fisher Scientific Inc

Price (delayed)

$434.86

Market cap

$164.16B

P/E Ratio

25.45

Dividend/share

$1.64

EPS

$17.09

Enterprise value

$194.21B

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry . ...

Highlights
The stock's price to earnings (P/E) is 24% less than its last 4 quarters average of 33.3 and 19% less than its 5-year quarterly average of 31.5
TMO's EPS is up by 9% year-on-year and by 3.1% since the previous quarter
The debt has increased by 9% QoQ but it has decreased by 4% YoY

Key stats

What are the main financial stats of TMO
Market
Shares outstanding
377.49M
Market cap
$164.16B
Enterprise value
$194.21B
Valuations
Price to earnings (P/E)
25.45
Price to book (P/B)
3.32
Price to sales (P/S)
3.83
EV/EBIT
23.35
EV/EBITDA
17.2
EV/Sales
4.53
Earnings
Revenue
$42.9B
Gross profit
$17.73B
Operating income
$7.39B
Net income
$6.52B
EBIT
$8.32B
EBITDA
$11.29B
Free cash flow
$6.79B
Per share
EPS
$17.09
EPS diluted
$17.05
Free cash flow per share
$17.96
Book value per share
$130.92
Revenue per share
$113.49
TBVPS
$98.48
Balance sheet
Total assets
$99.04B
Total liabilities
$49.68B
Debt
$34.19B
Equity
$49.39B
Working capital
$10.2B
Liquidity
Debt to equity
0.69
Current ratio
1.77
Quick ratio
1.09
Net debt/EBITDA
2.66
Margins
EBITDA margin
26.3%
Gross margin
41.3%
Net margin
15.2%
Operating margin
17.2%
Efficiency
Return on assets
6.6%
Return on equity
13.3%
Return on invested capital
15.8%
Return on capital employed
9.7%
Return on sales
19.4%
Dividend
Dividend yield
0.38%
DPS
$1.64
Payout ratio
9.6%

TMO stock price

How has the Thermo Fisher Scientific stock price performed over time
Intraday
0.96%
1 week
1.29%
1 month
4.75%
1 year
-19.87%
YTD
-16.41%
QTD
7.25%

Financial performance

How have Thermo Fisher Scientific's revenue and profit performed over time
Revenue
$42.9B
Gross profit
$17.73B
Operating income
$7.39B
Net income
$6.52B
Gross margin
41.3%
Net margin
15.2%

TMO financials

Thermo Fisher Scientific's net income has increased by 8% YoY and by 2.8% from the previous quarter
The net margin has increased by 7% YoY and by 2.7% QoQ
The operating income has grown by 6% YoY
Thermo Fisher Scientific's operating margin has increased by 4.9% YoY

Price vs fundamentals

How does TMO's price correlate with its fundamentals

TMO Price vs fundamentals

TMO Earnings waterfall

TMO Price vs fair value

Growth

What is Thermo Fisher Scientific's growth rate over time

TMO growth chart

Valuation

What is Thermo Fisher Scientific stock price valuation
P/E
25.45
P/B
3.32
P/S
3.83
EV/EBIT
23.35
EV/EBITDA
17.2
EV/Sales
4.53

Valuation vs average

Price to earnings (P/E)

The stock's price to earnings (P/E) is 24% less than its last 4 quarters average of 33.3 and 19% less than its 5-year quarterly average of 31.5
TMO's EPS is up by 9% year-on-year and by 3.1% since the previous quarter

Price to book (P/B)

The P/B is 34% below the 5-year quarterly average of 5.0 and 23% below the last 4 quarters average of 4.3
The company's equity rose by 9% YoY

Price to sales (P/S)

The P/S is 26% below the 5-year quarterly average of 5.2 and 22% below the last 4 quarters average of 4.9

Efficiency

How efficient is Thermo Fisher Scientific business performance
TMO's ROA is up by 6% YoY and by 3.1% from the previous quarter
TMO's ROS is up by 3.2% year-on-year

Dividends

What is TMO's dividend history
DPS
$1.64
Dividend yield
0.38%
Payout ratio
9.6%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Thermo Fisher Scientific financials performed over time

Assets vs liabilities

The total assets is 99% greater than the total liabilities
The current ratio has increased by 7% since the previous quarter and by 4.1% year-on-year
Thermo Fisher Scientific's quick ratio has increased by 6% from the previous quarter

Debt vs equity

The debt is 31% lower than the equity
Thermo Fisher Scientific's debt to equity has decreased by 12% YoY but it has increased by 10% QoQ
The company's equity rose by 9% YoY

Balance sheet

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.